Immunogenx
ImmunogenX, Inc. is a clinical-stage company founded in 2013 and supported by a team of world renowned scientists and collaborators. ImmunogenX was formed to address critical needs for individuals with suspected or diagnosed celiac disease. ImmunogenX is currently conducting two Phase 2b clinical research trials and has completed one study on latiglutenase, an investigational medication designed to relieve common symptoms suffered by those with celiac disease.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
1
tools in use
Monthly traffic
97
organic / mo
Sign up free to see all 2 verified contacts at Immunogenx
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
- MD
Matt Dickason
Chief Operating Officer · General Business & Management
EmailPhone - VL
Vasiliy Loskutov
Project Analyst · Operations
EmailPhone
Showing 2 of 2 verified contacts
Top roles at Immunogenx
2 distinct titles indexed · top 2 shown.
- 1chief operating officer
- 1project analyst
Sign up to unlock all 2 contacts at Immunogenx
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Immunogenx
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.